2021 Q3 Form 10-Q Financial Statement

#000155837021014179 Filed on November 03, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2021 Q2 2020 Q3
Revenue $1.110B $999.9M $564.0M
YoY Change 96.89% 182.83% 99.88%
Cost Of Revenue $1.031B $920.0M $517.2M
YoY Change 99.33% 188.21% 99.61%
Gross Profit $79.54M $79.92M $46.80M
YoY Change 69.96% 132.32% 103.48%
Gross Profit Margin 7.16% 7.99% 8.3%
Selling, General & Admin $68.38M $63.40M $31.63M
YoY Change 116.21% 143.47% 28.14%
% of Gross Profit 85.96% 79.34% 67.57%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.694M $1.517M $1.000M
YoY Change 69.4% 68.56% 66.67%
% of Gross Profit 2.13% 1.9% 2.14%
Operating Expenses $1.099B $983.4M $548.8M
YoY Change 100.31% 184.87% 93.36%
Operating Profit $11.17M $16.51M $15.22M
YoY Change -26.64% 98.5% -1027.1%
Interest Expense $2.000K -$1.000K
YoY Change
% of Operating Profit 0.02% -0.01%
Other Income/Expense, Net -$237.0K -$55.00K -$80.00K
YoY Change 196.25% 139.13% -53.76%
Pretax Income $10.93M $16.46M $15.14M
YoY Change -27.82% 98.38% -934.33%
Income Tax -$12.90M -$20.59M $200.0K
% Of Pretax Income -118.02% -125.08% 1.32%
Net Earnings $23.82M $37.05M $14.97M
YoY Change 59.12% 347.73% -910.5%
Net Earnings / Revenue 2.15% 3.71% 2.65%
Basic Earnings Per Share $0.16 $0.25 $0.11
Diluted Earnings Per Share $0.15 $0.24 $0.10
COMMON SHARES
Basic Shares Outstanding 146.9M 145.6M 138.5M
Diluted Shares Outstanding 157.3M 157.3M 150.9M

Balance Sheet

Concept 2021 Q3 2021 Q2 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $98.06M $107.4M $91.90M
YoY Change 6.71% 68.89% 164.84%
Cash & Equivalents $98.06M $107.4M $91.87M
Short-Term Investments
Other Short-Term Assets $78.23M $105.5M $25.20M
YoY Change 210.45% 409.51% 140.0%
Inventory
Prepaid Expenses
Receivables $129.8M $134.3M $93.48M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $306.1M $347.1M $210.5M
YoY Change 45.42% 153.75% 158.95%
LONG-TERM ASSETS
Property, Plant & Equipment $13.19M $11.17M $6.751M
YoY Change 95.32% 83.63% 12.52%
Goodwill $12.95M $12.95M $10.56M
YoY Change 22.61% 56.95%
Intangibles $7.693M $7.934M $3.521M
YoY Change 118.49% 179.66%
Long-Term Investments
YoY Change
Other Assets $39.03M $15.34M $0.00
YoY Change
Total Long-Term Assets $75.49M $48.00M $21.68M
YoY Change 248.27% 165.59% 28.26%
TOTAL ASSETS
Total Short-Term Assets $306.1M $347.1M $210.5M
Total Long-Term Assets $75.49M $48.00M $21.68M
Total Assets $381.6M $395.1M $232.2M
YoY Change 64.36% 155.13% 136.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.555M $6.318M $2.610M
YoY Change 227.78% 284.77% 117.5%
Accrued Expenses $110.3M $119.6M $91.33M
YoY Change 20.73% 122.15% 128.9%
Deferred Revenue $69.41M $93.76M $22.12M
YoY Change 213.84% 438.71%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $906.0K $916.0K $1.492M
YoY Change -39.28% -5.57% 49.2%
Total Short-Term Liabilities $189.5M $220.9M $118.3M
YoY Change 60.21% 196.16% 136.07%
LONG-TERM LIABILITIES
Long-Term Debt $1.736M $1.716M $2.749M
YoY Change -36.85% 8.26% 52.72%
Other Long-Term Liabilities $849.0K $334.0K $100.0K
YoY Change 749.0% 67.0% -90.91%
Total Long-Term Liabilities $1.736M $1.716M $2.749M
YoY Change -36.85% 8.26% -5.21%
TOTAL LIABILITIES
Total Short-Term Liabilities $189.5M $220.9M $118.3M
Total Long-Term Liabilities $1.736M $1.716M $2.749M
Total Liabilities $192.1M $222.9M $121.1M
YoY Change 58.55% 192.02% 128.56%
SHAREHOLDERS EQUITY
Retained Earnings $20.80M $2.734M -$46.88M
YoY Change -144.37% -104.42%
Common Stock $347.7M $1.000K $1.000K
YoY Change 34767000.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares $6.013M $4.725M $2.370M
Shareholders Equity $188.6M $171.2M $110.9M
YoY Change
Total Liabilities & Shareholders Equity $381.6M $395.1M $232.2M
YoY Change 64.36% 155.13% 136.46%

Cashflow Statement

Concept 2021 Q3 2021 Q2 2020 Q3
OPERATING ACTIVITIES
Net Income $23.82M $37.05M $14.97M
YoY Change 59.12% 347.73% -910.5%
Depreciation, Depletion And Amortization $1.694M $1.517M $1.000M
YoY Change 69.4% 68.56% 66.67%
Cash From Operating Activities $30.99M $88.53M $43.20M
YoY Change -28.27% 210.61% 188.0%
INVESTING ACTIVITIES
Capital Expenditures -$3.550M -$3.309M -$1.600M
YoY Change 121.88% 154.54% 6.67%
Acquisitions
YoY Change
Other Investing Activities -$3.004M $0.00 -$1.400M
YoY Change 114.57%
Cash From Investing Activities -$6.554M -$3.309M -$3.000M
YoY Change 118.47% 154.54% 100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -58.01M -54.54M -7.100M
YoY Change 717.01% 5353.6% -16.47%
NET CHANGE
Cash From Operating Activities 30.99M 88.53M 43.20M
Cash From Investing Activities -6.554M -3.309M -3.000M
Cash From Financing Activities -58.01M -54.54M -7.100M
Net Change In Cash -33.57M 30.68M 33.10M
YoY Change -201.43% 17.1% 562.0%
FREE CASH FLOW
Cash From Operating Activities $30.99M $88.53M $43.20M
Capital Expenditures -$3.550M -$3.309M -$1.600M
Free Cash Flow $34.54M $91.83M $44.80M
YoY Change -22.91% 208.17% 171.52%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001495932
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2021Q3 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2020Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2021Q3 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2020Q4 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2021Q3 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2020Q4 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38493
dei Entity Registrant Name
EntityRegistrantName
EXP WORLD HOLDINGS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0681092
dei Entity Address Address Line1
EntityAddressAddressLine1
2219 Rimland Drive, Suite 301
dei Entity Address City Or Town
EntityAddressCityOrTown
Bellingham
dei Entity Address State Or Province
EntityAddressStateOrProvince
WA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
98226
dei City Area Code
CityAreaCode
360
dei Local Phone Number
LocalPhoneNumber
685-4206
dei Security12b Title
Security12bTitle
Common Stock, par value $0.00001 per share
dei Trading Symbol
TradingSymbol
EXPI
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
147537072
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
98064000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3957000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
100143000
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
69406000
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
27781000
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1901000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1879000
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
129843000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
76951000
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8828000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7350000
CY2021Q3 us-gaap Assets Current
AssetsCurrent
306141000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
212225000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13186000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7848000
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2639000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
819000
CY2021Q3 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
3009000
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7693000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8350000
CY2021Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
36020000
CY2021Q3 us-gaap Goodwill
Goodwill
12945000
CY2020Q4 us-gaap Goodwill
Goodwill
12945000
CY2021Q3 us-gaap Assets
Assets
381633000
CY2020Q4 us-gaap Assets
Assets
242187000
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
8555000
CY2021Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
69406000
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
27781000
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
110268000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
62750000
CY2021Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
906000
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1416000
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
345000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
746000
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
189480000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
96650000
CY2021Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1736000
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2876000
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
849000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
74000
CY2021Q3 us-gaap Liabilities
Liabilities
192065000
CY2020Q4 us-gaap Liabilities
Liabilities
99600000
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
900000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
900000000
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
153549867
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
147537072
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
146677786
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
144143292
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
1000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2021Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
347670000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
218492000
CY2021Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
6012795
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2534494
CY2021Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
180097000
CY2020Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
37994000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
20800000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-39162000
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Before Tax1
AccumulatedOtherComprehensiveIncomeLossBeforeTax1
187000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Before Tax1
AccumulatedOtherComprehensiveIncomeLossBeforeTax1
247000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
188561000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
141584000
CY2021Q3 us-gaap Minority Interest
MinorityInterest
1007000
CY2020Q4 us-gaap Minority Interest
MinorityInterest
1003000
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
189568000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
142587000
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
381633000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
242187000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1110480000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
564017000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2694200000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1188963000
CY2021Q3 expi Commissions And Other Agent Related Costs
CommissionsAndOtherAgentRelatedCosts
1030937000
CY2020Q3 expi Commissions And Other Agent Related Costs
CommissionsAndOtherAgentRelatedCosts
517169000
expi Commissions And Other Agent Related Costs
CommissionsAndOtherAgentRelatedCosts
2481254000
expi Commissions And Other Agent Related Costs
CommissionsAndOtherAgentRelatedCosts
1079739000
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
64615000
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
30130000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
171636000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
82145000
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3761000
CY2020Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1495000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
8701000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3326000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
1099313000
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
548794000
us-gaap Operating Expenses
OperatingExpenses
2661591000
us-gaap Operating Expenses
OperatingExpenses
1165210000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
11167000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
15223000
us-gaap Operating Income Loss
OperatingIncomeLoss
32609000
us-gaap Operating Income Loss
OperatingIncomeLoss
23753000
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-239000
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-80000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-159000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-129000
CY2021Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-5000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-34000
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-237000
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-80000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-164000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-163000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
10930000
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
15143000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
14970000
us-gaap Net Income Loss
NetIncomeLoss
65717000
us-gaap Net Income Loss
NetIncomeLoss
23410000
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.11
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
32445000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
23590000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-12884000
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
225000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-33258000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
295000
CY2021Q3 us-gaap Profit Loss
ProfitLoss
23814000
CY2020Q3 us-gaap Profit Loss
ProfitLoss
14918000
us-gaap Profit Loss
ProfitLoss
65703000
us-gaap Profit Loss
ProfitLoss
23295000
CY2021Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-7000
CY2020Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-52000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-14000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-115000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
23821000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.45
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.10
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
146862978
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
138513465
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
145610008
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
135207101
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
157345924
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
150917721
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
157838134
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
147091720
CY2021Q3 us-gaap Profit Loss
ProfitLoss
23814000
CY2020Q3 us-gaap Profit Loss
ProfitLoss
14918000
us-gaap Profit Loss
ProfitLoss
65703000
us-gaap Profit Loss
ProfitLoss
23295000
CY2021Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-7000
CY2020Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-52000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-14000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-115000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
23821000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
14970000
us-gaap Net Income Loss
NetIncomeLoss
65717000
us-gaap Net Income Loss
NetIncomeLoss
23410000
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-131000
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-76000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-60000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-129000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
23690000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
14894000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
65657000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
23281000
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-131000
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-76000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-60000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-129000
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
189568000
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
111063000
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
189568000
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
111063000
us-gaap Profit Loss
ProfitLoss
65703000
us-gaap Profit Loss
ProfitLoss
23295000
us-gaap Depreciation
Depreciation
3572000
us-gaap Depreciation
Depreciation
2403000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
939000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
382000
expi Amortization Expense Related To Discount Applied In Business Combination
AmortizationExpenseRelatedToDiscountAppliedInBusinessCombination
152000
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
22000
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
1209000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-5000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-34000
expi Share Based Compensation Agent Growth Incentive Programs
ShareBasedCompensationAgentGrowthIncentivePrograms
18129000
expi Share Based Compensation Agent Growth Incentive Programs
ShareBasedCompensationAgentGrowthIncentivePrograms
10476000
us-gaap Share Based Compensation
ShareBasedCompensation
9608000
us-gaap Share Based Compensation
ShareBasedCompensation
4179000
expi Share Based Compensation Agent Equity Program
ShareBasedCompensationAgentEquityProgram
101691000
expi Share Based Compensation Agent Equity Program
ShareBasedCompensationAgentEquityProgram
39226000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-36020000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
52913000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
66490000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1510000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-494000
us-gaap Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
-41625000
us-gaap Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
-15128000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4597000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
16000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
44561000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
58702000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-150000
expi Proceeds From Payments For Other Operating Activities
ProceedsFromPaymentsForOtherOperatingActivities
-1446000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
198413000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
89206000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9159000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3691000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1500000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1362000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
573000
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
3004000
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
25000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13663000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5651000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
142103000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
21330000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2695000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4710000
expi Lease Termination Non Cash Investing And Financing Activities
LeaseTerminationNonCashInvestingAndFinancingActivities
200000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2381000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
33000
expi Property Plant And Equipment Purchases In Accounts Payable
PropertyPlantAndEquipmentPurchasesInAccountsPayable
150000
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
19000
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
106000
us-gaap Payments Of Dividends
PaymentsOfDividends
5755000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-145144000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-16514000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-60000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-129000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
39546000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
66912000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
127924000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47074000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
167470000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
113986000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1060000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
676000
expi Lease Termination Non Cash Investing And Financing Activities
LeaseTerminationNonCashInvestingAndFinancingActivities
346000
expi Property Plant And Equipment Purchases In Accounts Payable
PropertyPlantAndEquipmentPurchasesInAccountsPayable
111000
expi Noncash Or Part Noncash Acquisition Incurred Value Of Liabilities
NoncashOrPartNoncashAcquisitionIncurredValueOfLiabilities
1500000
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
140000
us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
On January 15, 2021, the Company’s Board of Directors approved a two-for-one stock split in the form of a stock dividend to stockholders of record as of January 29, 2021 (the “Stock Split”). The Stock Split was effected on February 12, 2021.
CY2021Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
2
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimate</span>s</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;">and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to allowance for credit losses, legal contingencies, income taxes, revenue recognition, stock-based compensation, goodwill, and deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</p>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><span style="font-style:italic;font-weight:bold;">Reclassifications</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;">When necessary, the Company will reclassify certain amounts in prior-period financial statements to conform to the current period’s presentation. No material reclassifications occurred during the current period.</p>
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
40087000
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
6987000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47074000
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
91871000
CY2020Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
22115000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
113986000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
100143000
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
27781000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
127924000
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
98064000
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
69406000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
167470000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13186000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7848000
CY2021Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
9612000
CY2021Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1919000
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7693000
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
9330000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
980000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8350000
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
318000
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1901000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1879000
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
152000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
939000
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
19378000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
13848000
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10308000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6738000
CY2021Q3 expi Property Plant And Equipment Excluding Assets Under Construction
PropertyPlantAndEquipmentExcludingAssetsUnderConstruction
9070000
CY2020Q4 expi Property Plant And Equipment Excluding Assets Under Construction
PropertyPlantAndEquipmentExcludingAssetsUnderConstruction
7110000
CY2021Q3 expi Assets Under Development
AssetsUnderDevelopment
4116000
CY2020Q4 expi Assets Under Development
AssetsUnderDevelopment
738000
CY2021Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1376000
CY2020Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
852000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3572000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2403000
CY2021Q3 us-gaap Goodwill
Goodwill
12945000
CY2020Q4 us-gaap Goodwill
Goodwill
12945000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.05043
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
382000
CY2021Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
0
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
147000
CY2020Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
103000
us-gaap Operating Lease Cost
OperatingLeaseCost
358000
us-gaap Operating Lease Cost
OperatingLeaseCost
328000
CY2021Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
13000
CY2020Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y9M18D
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
90000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
90000
CY2021Q3 expi Lessee Operating Lease Liability Payments Due Year Five And After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive
495000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1206000
CY2021Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
12000
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
1194000
CY2020Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
2000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
37000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
12000
CY2021Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
1397000
CY2020Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
103000
us-gaap Operating Lease Payments
OperatingLeasePayments
1858000
us-gaap Operating Lease Payments
OperatingLeasePayments
327000
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y
CY2020Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y9M18D
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y
CY2020Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.04851
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.05043
CY2020Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.04851
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
84000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
281000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
166000
CY2020Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
2047778
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2534494
CY2019Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
925364
CY2021Q3 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
1287499
CY2020Q3 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
321974
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
151146986
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
141160576
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
146677786
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
132398616
CY2021Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
337234
CY2020Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1306046
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2682142
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
5706624
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
153549867
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
144645984
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
153549867
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
144645984
CY2020Q4 expi Stock Compensation Liability Activity
StockCompensationLiabilityActivity
2093000
CY2021Q1 expi Increase Decrease In Stock Grant Liability
IncreaseDecreaseInStockGrantLiability
1221000
CY2021Q2 expi Increase Decrease In Stock Grant Liability
IncreaseDecreaseInStockGrantLiability
1402000
expi Stock Awards Reclassified From Liability To Equity
StockAwardsReclassifiedFromLiabilityToEquity
1496000
expi Increase Decrease In Stock Grant Liability
IncreaseDecreaseInStockGrantLiability
1830000
CY2021Q3 expi Stock Compensation Liability Activity
StockCompensationLiabilityActivity
5050000
CY2018Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
25000000.0
CY2020Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
75000000.0
CY2020Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
75000000.0
CY2020Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
400000000.0
CY2021Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
4725296
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
11884619
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
3478301
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
1444388
CY2021Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
6012795
CY2020Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
2369752
CY2021Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
6012795
CY2020Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
2369752
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
23821000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
14970000
us-gaap Net Income Loss
NetIncomeLoss
65717000
us-gaap Net Income Loss
NetIncomeLoss
23410000
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
146862978
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
138513465
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
145610008
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
135207101
CY2021Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
10482946
CY2020Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
12404256
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
12228126
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
157345924
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
150917721
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
157838134
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
147091720
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.11
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.45
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.10
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
132704
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
154870
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
75680
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
162063
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-12900000
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
200000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-33300000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
300000
CY2021Q2 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-13000000
CY2021Q3 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-22000000
CY2021Q3 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2020Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1

Files In Submission

Name View Source Status
0001558370-21-014179-index-headers.html Edgar Link pending
0001558370-21-014179-index.html Edgar Link pending
0001558370-21-014179.txt Edgar Link pending
0001558370-21-014179-xbrl.zip Edgar Link pending
expi-20210930.xsd Edgar Link pending
expi-20210930x10q.htm Edgar Link pending
expi-20210930x10q001.jpg Edgar Link pending
expi-20210930x10q_htm.xml Edgar Link completed
expi-20210930xex31d1.htm Edgar Link pending
expi-20210930xex31d2.htm Edgar Link pending
expi-20210930xex32d1.htm Edgar Link pending
expi-20210930xex32d2.htm Edgar Link pending
expi-20210930_cal.xml Edgar Link unprocessable
expi-20210930_def.xml Edgar Link unprocessable
expi-20210930_lab.xml Edgar Link unprocessable
expi-20210930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending